Bloomage BioTechnology Corporation Limited (SHA:688363)
35.18
+0.21 (0.60%)
Sep 4, 2026, 3:00 PM CST
SHA:688363 Revenue
Bloomage BioTechnology Corporation had revenue of 926.77M CNY in the quarter ending June 30, 2026, a decrease of -21.64%. This brings the company's revenue in the last twelve months to 3.69B, down -23.36% year-over-year. In the year 2025, Bloomage BioTechnology Corporation had annual revenue of 4.20B, down -21.82%.
Revenue (ttm)
3.69B
Revenue Growth
-23.36%
P/S Ratio
4.56
Revenue / Employee
999.07K
Employees
3,698
Market Cap
16.83B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.20B | -1.17B | -21.82% |
| Dec 31, 2024 | 5.37B | -705.15M | -11.61% |
| Dec 31, 2023 | 6.08B | -283.27M | -4.45% |
| Dec 31, 2022 | 6.36B | 1.41B | 28.53% |
| Dec 31, 2021 | 4.95B | 2.32B | 87.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zibo Qixiang Tengda Chemical | 27.19B |
| Tangshan Sanyou Chemical Industries Co.,Ltd | 19.07B |
| Zhejiang Runtu | 6.61B |
| Shandong Dongyue Organosilicon Materials | 4.11B |
| PhiChem | 3.49B |
| Weihai Guangwei Composites | 2.98B |
| Jinhong Gas | 2.94B |
| Crystal Clear Electronic Material Co.,Ltd | 1.79B |
Bloomage BioTechnology Corporation News
- 8 days ago - Bloomage BioTechnology Corporation Quarterly report: Q2 2026 - Filings
- 4 months ago - Bloomage BioTechnology Corporation Quarterly report: Q1 2026 - Filings
- 4 months ago - Bloomage BioTechnology Corporation Annual report: Q4 2025 - Filings
- 10 months ago - Bloomage BioTechnology Corporation Quarterly report: Q3 2025 - Filings